FDA inspection
Pfizer Inc.: FDA inspection ending Feb 12, 2001
FDA inspection 61216 · No Action Indicated (NAI) · New York, NY
Key facts
| Inspection ID | 61216 |
|---|---|
| Firm | Pfizer Inc. |
| FEI number | 2416101 |
| Address | 235 East 42nd Street |
| City | New York |
| State | NY |
| ZIP | 10017-5703 |
| Fiscal year | 2001 |
| Inspection end date | Feb 12, 2001 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data